Table 3.

Ongoing Clinical Trials of Conventional Radio- and Chemotherapy in Atypical Teratoid/Rhabdoid Tumors

Clinicaltrials. gov ID	Recruitment Status	Phases	Intervention
NCT00003141	Completed	Phase 1	HSCT; carboplatin, cisplatin, cyclophosphamide, etoposide, thiotepa, vincristine
NCT00007813	Unknown	Phase 1	HSCT; carboplatin, cyclophosphamide, etoposide
NCT00047177	Completed	Phase 2	Oxaliplatin
NCT00053118	Completed	Phase 1	HSCT; carboplatin
NCT00084838	Completed	Phase 2	Radiation; cisplatin, cyclophosphamide, cytarabine, dexrazoxane, doxorubicin, etoposide, methotrexate, temozolomide, hydrocortisone, vincristine, dactinomycin
NCT00085202	Active, not recruiting	Phase 3	HSCT; radiation; cisplatin, cyclophosphamide, vincristine
NCT00100880	Completed	Phase 1	Lenalidomide
NCT00112619	Terminated	Phase 1	Topotecan
NCT00138216	Completed	Phase 1	Irinotecan, temoxolomide, vincristine
NCT00392886	Unknown	Phase 3	HSCT; radiation; carboplatin, cisplatin, cyclophosphamide, etoposide, methotrexate, temozolomide, thiotepa, vincristine
NCT00602667	Active, not recruiting	Phase 2	Risk-stratified combination of methotrexate, vincristine, cisplatin, cyclophosphamide, carboplatin, etoposide, topotecan, erlotinib, vinblastine
NCT00623077	Terminated	Phase 1	Radiation; busulfan, etoposide, ifosfamide, melphalan, thiotepa
NCT00653068	Active, not recruiting	Phase 3	HSCT; methotrexate, etoposide, cyclophosphamide, cisplatin, carboplatin, thiotepa, vincristine
NCT00983398	Recruiting	Phase 1/2	Carboplatin, mannitol, melphalan
NCT01331135	Active, not recruiting	Phase 1	Sirolimus
NCT01505569	Recruiting	Phase 1	HSCT; radiation; etoposide, busulfan, melphalan, thiotepa, carboplatin, paclitaxel
NCT01737671	Completed	Phase 1	IT methotrexate
NCT02684071	Recruiting	Phase 2	IT methotrexate, topotecan, cyclophosphamide

Abbreviations: HSCT, hematopoietic stem cell transplantation; ID, identification; IT, intrathecal.